Thirteen years into China’s antitrust regime, Chinese antitrust enforcement reflects both Western trends, including a focus on technology companies and more aggressive enforcement, and…
An important chapter for Hong Kong’s capital markets is ready to be unveiled as the rules for establishing a new SPACs listing regime are set to take effect on January 1, 2022. In this…
Davis Polk partners Will Pearce and Louis Goldberg are delighted to be contributing editors of the updated edition of Lexology Getting the Deal Through: Private M&A 2022, a…
2020 marked the twelfth anniversary of China’s Anti-Monopoly Law. Over the course of the past year, the Chinese authorities made it clear that they expect to be full participants in the…
Davis Polk partners Will Pearce and Louis Goldberg are delighted to be contributing editors of the updated edition of Getting the Deal Through: Private M&A 2021, a comprehensive…
Since April 2018, the Hong Kong Stock Exchange has had a regime for listing biotech companies that have yet to record any revenue, which is an important first step towards opening up the…
Since April 2018, the Hong Kong Stock Exchange has had a regime for listing innovative “new economy” companies with dual-class share structures, which represents a key step toward opening…
In addition to antitrust and other regulatory approvals, an increasing number of jurisdictions have now adopted FDI screening mechanisms. These aim to determine whether investments by…
